Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zhou

Showing results (821-830 of 929) with videos related to

Pageof 93
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 13, 2023
[The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis]S J Zhong, J J Gao, P Tang, et al.
The Journal of Clinical Investigation|January 29, 2019
Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cellsBai Cui, Yuanyuan Luo, Pengfei Tian, et al.
American Journal of Human Genetics|September 6, 2001
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromesX P Zhou, K Woodford-Richens, R Lehtonen, et al.
Carcinogenesis|June 25, 2015
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisJosiah Ochieng, Gladys N Nangami, Olugbemiga Ogunkua, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 22, 2024
[Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study]X Z Liu, S J Zhou, J Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients]A N Sun, X P Tian, X S Cao, et al.
Nature Reviews. Molecular Cell Biology|April 18, 2020
Guidelines and definitions for research on epithelial-mesenchymal transitionJing Yang, Parker Antin, Geert Berx, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 93

Showing results (821-830 of 929) with videos related to

Sort By:
Pageof 93
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 13, 2023
[The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis]S J Zhong, J J Gao, P Tang, et al.
The Journal of Clinical Investigation|January 29, 2019
Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cellsBai Cui, Yuanyuan Luo, Pengfei Tian, et al.
American Journal of Human Genetics|September 6, 2001
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromesX P Zhou, K Woodford-Richens, R Lehtonen, et al.
Carcinogenesis|June 25, 2015
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisJosiah Ochieng, Gladys N Nangami, Olugbemiga Ogunkua, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 22, 2024
[Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study]X Z Liu, S J Zhou, J Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients]A N Sun, X P Tian, X S Cao, et al.
Nature Reviews. Molecular Cell Biology|April 18, 2020
Guidelines and definitions for research on epithelial-mesenchymal transitionJing Yang, Parker Antin, Geert Berx, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 8, 2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]X S Zhang, B C Liu, X Du, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia]X S Zhang, B C Liu, X Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 93